CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The EUROEWING Consortium aims to improve survival rates for Ewing Sarcomas, a rare bone cancer affecting young people, through comprehensive clinical trials and translational research. The project focuses on enhancing treatment protocols and patient access to innovative therapies to combat metastases and improve outcom…
Ewing Sarcomas (ES) are fatal, rare bone cancers particularly affecting young people.
About 60% of patients achieve long term survival with current treatment but there has been no improvement in this proportion for 25 years.
Treatment is unsuccessful because chemotherapy fails to prevent the development of, or to effectively treat established, metastases.
In addition, of the 600 new cases of ES occurring in the EU each year, less than half will receive treatment ‘appropriate’ to deliver the mos…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Bruxelles / Brussel
Type: Research institute
Activity type: Research Organisations
SME: No
Germany, MUENSTER
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Birmingham
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
